Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Carcinoma, Merkel Cell × Carboplatin × Clear all

Phase

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 28 Small Cell Lung Carcinoma 11 Triple Negative Breast Neoplasms 10 Breast Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 7 Lung Neoplasms 6 Endometrial Neoplasms 6 Ovarian Neoplasms 5 Recurrence 4 Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Esophageal Neoplasms 3 Respiratory Tract Neoplasms 2 Neoplasm Metastasis 2 NSCLC 2 Mouth Neoplasms 2 Laryngeal Neoplasms 2 Uterine Cervical Neoplasms 1 Unresectable Locally Advanced or Metastatic Solid Tumors 1 Thymoma 1 Thymic epithelial tumor 1 Thoracic Neoplasms 1 Stomach Neoplasms 1 Stereotactic Radiotherapy; Evoximab (AK112); New Adjuvant Therapy for Non-small Cell Lung Cancer 1 Stage III and IV Ovarian Cancer 1 Squamous Non-small Cell Lung Cancer 1 Squamous NSCLC 1 Solid Tumor Cancer 1 Salivary Gland Malignant Neoplasms 1 Respiratory Tract Diseases 1

Interventions

pembrolizumab 1 decitabine and cedazuridine drug combination 1 cemiplimab 1 Etoposide 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06086288 2023-10-17

PANDORA

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Not yet recruiting

Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡